Panobinostat recommended by CHMP for EU approval to treat multiple myeloma
26 June 2015 | By Victoria White
The CHMP of the EMA have adopted a positive opinion for panobinostat capsules for the treatment of patients with multiple myeloma...
List view / Grid view
News
European Medicines Agency validates Alprolix marketing authorisation application
26 June 2015 | By Victoria White
Biogen and SOBI have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for Alprolix...
Clever FlexiBulk Tip Packs – save space and effort in your lab
26 June 2015 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, introduces a completely new concept for packaging pipette tips: FlexiBulk...
Sartorius Stedim Biotech launches a new single-use harvesting technology for high cell density cultures up to 2,000 L
26 June 2015 | By Sartorius Stedim Biotech (SSB)
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced Sartoclear Dynamics®, a clarification system featuring new single-use technology for harvesting mammalian cell cultures with high cell densities...
CHMP recommends granting marketing authorisation to Raxone for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
26 June 2015 | By Victoria White
CHMP has recommended granting marketing authorisation to Raxone for the treatment of visual impairment in patients with Leber's Hereditary Optic Neuropathy...
Immune Pharmaceuticals initiates Phase II trials of bertilimumab in ulcerative colitis and bullous pemphigoid
26 June 2015 | By Victoria White
Immune Pharmaceuticals has initiated a Phase II trial of bertilimumab in ulcerative colitis and will initiate a Phase II bullous pemphigoid trial in July...
Global gene therapy deals sky-rocketed to nearly $5 billion in 2014, says GlobalData
26 June 2015 | By Victoria White
The number of deals in the global gene therapy market more than doubled in 2014, with their combined value rising spectacularly to $4.9...
EC approves Simponi for the treatment of severe, active non-radiographic axial spondyloarthritis
26 June 2015 | By Victoria White
The EC has approved Simponi (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA)...
UK court rules in favour of Lilly in Alimta vitamin regimen patent lawsuit
26 June 2015 | By Victoria White
The UK Court of Appeal has ruled in favour of Lilly in the Actavis v. Eli Lilly and Company Alimta vitamin regimen patent lawsuit...
Mayor of London considers £10bn ‘megafund’ as option to boost drug development
25 June 2015 | By Victoria White
Plans to create a £10bn megafund that would make it easier for drug development will be discussed at a conference hosted by the Mayor of London’s Office...
Patient enrollment in Phase III CONCERTO trial of laquinimod completed
25 June 2015 | By Victoria White
The patient enrollment for the Phase III CONCERTO trial of laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS) has been finalised...
Epilespy treatment perampanel receives marketing authorisation for primary generalised tonic-clonic seizures
25 June 2015 | By Victoria White
The EC has granted marketing authorisation approval for perampanel for primary generalised tonic-clonic (PGTC) seizures in patients with epilepsy...
Viscosupplementation market value to exceed $2.6 billion by 2021, says GlobalData
25 June 2015 | By Victoria White
The viscosupplementation market value will increase to a little under $2.64 billion by 2021, across the ten major markets, says GlobalData...
Data from four trials support the safety and tolerability of hESC-derived retinal pigment epithelium
25 June 2015 | By
Results of four trials provide additional evidence supporting the safety and tolerability of hESC-derived retinal pigment epithelium...
Clinical trial of Futura Medical’s MED2002 commences
25 June 2015 | By Victoria White
Futura Medical has received all of the regulatory approvals needed to begin its efficacy trial of erectile dysfunction treatment MED2002...
